Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
T-knife Therapeutics Inc.
BioCentury | Mar 24, 2023
Product Development
Landscape of emerging T cell therapies in cancer
Four axes of risk map how companies founded in the last five years are innovating in CAR T and TCR T cells
BioCentury | Feb 9, 2023
Management Tracks
Bill Anderson becomes CEO of Bayer
Plus: High leaving AskBio, and updates from Verily, PhRMA, MOMA and more
BioCentury | Nov 25, 2021
Product Development
Next-gen TILs and TCRs face a durability challenge
SITC provides a snapshot of how companies are enhancing TIL and TCR therapies
BioCentury | Aug 4, 2021
Management Tracks
Arbuckle becomes COO at Vertex
Plus: GlycoMimetics names Semerjian as King’s successor, plus updates from Pieris, Assembly and more
BioCentury | Jul 12, 2021
Management Tracks
Morrison joins Atlas as venture partner; plus Veracyte, FibroGen, T-Knife, Sherlock and more
Items per page:
1 - 5 of 5